Skip to main content
. 2022 Oct 5;41(44):4905–4915. doi: 10.1038/s41388-022-02483-8

Fig. 2. ESR1 mutant MCF7 clones grow in the absence of estrogen but show differential sensitivity to SERDs.

Fig. 2

A, B Cells cultured in estrogen-depleted medium were treated with 10 nM estrogen, or vehicle. Shown is the fold difference in growth of individual mutant clones, relative to the growth of MCF7 cells after 9 days. The results for 10 nM estrogen addition to MCF7 cells, are shown for comparison. B Doubling times for MCF7 and mutant clones, determined from growth experiment undertaken on an Incucyte Zoom ±10 nM E2 over a 9-day period (see Supplementary Fig. 3 for the full data). Doubling times were calculated using the exponential growth equation in Graphpad Prism. C The heatmap shows relative difference in IC50 values for mutant clones relative to the IC50 for MCF7 cells, determined for each mutant clone. Also shown are the mRNA expression levels of mutant ER, as a percentage of total ER in each clone, determined by ddPCR (see Supplementary Figs. 4, 5 for complete data). D, E Mean growth relative to vehicle (DMSO) is shown following treatment of MCF7, MCF7-Y537S and MCF7-L536R clones for 6 days, with increasing concentrations of anti-estrogens. The graphs plot the results of three independent experiments; error bars show standard deviations (see Supplementary Fig. 4 for actual IC50 values).